Article
Protection of hematopoietic cells against combined O6-benzylguanine and chloroethylnitrosourea treatment by mutant forms of O6-methylguanine DNA methyltransferase.
Bone marrow transplantation - 1 May 2000
Williams D A, Maze R, Kurpad C, Pegg A, Erickson L C
Abstract excerpt
This report demonstrates that expression of the P140A O6-methylguanine DNA methyl transferase (MGMT) mutant via retrovirus-mediated gene transfer leads to significant, but modest, resistance of cells to both 6-benzylguanine (6-BG) depletion and treatment with 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU). Expression of the P140A/G156A double mutant appeared to be associated with reduced or unstable protein in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
